logo
episode-header-image
About this episode
On this episode, I discuss propranolol pharmacology, adverse reactions, and important drug interactions you should know. Propranolol (Inderal) is a non-selective beta-blocker. There are many indications for it including hypertension, tachycardia, atrial fibrillation, post-MI, chronic stable angina, essential tremors, migraine prophylaxis, esophageal varic ... Show More
Up next
Nov 20
Glycopyrrolate Pharmacology
Glycopyrrolate is an anticholinergic medication commonly used to reduce excessive secretions, particularly in palliative care, postoperative settings, and certain neurologic conditions. It works by blocking acetylcholine at muscarinic receptors, which decreases salivary and respi ... Show More
11m 47s
Nov 13
Bisacodyl (Dulcolax) Pharmacology
Bisacodyl, commonly known by the brand name Dulcolax, is a stimulant laxative widely used for short-term relief of constipation and bowel preparation before procedures. It works by directly stimulating the enteric nerves in the colon, increasing peristalsis, and promoting bowel e ... Show More
15m 53s
Nov 6
Fludrocortisone (Florinef) Pharmacology
On this podcast episode, I cover fludrocortisone. Fludrocortisone is a synthetic corticosteroid with potent mineralocorticoid activity and minimal glucocorticoid effects. It works primarily by promoting sodium reabsorption and potassium excretion in the distal renal tubules, lead ... Show More
14m 44s
Recommended Episodes
Jun 2024
Episode 908: Sympathomimetic Drugs
<p dir="ltr">Contributor: Taylor Lynch MD</p> <p dir="ltr">Educational Pearls:</p> <ul> <li dir="ltr" role="presentation">Overview: <ul> <li dir="ltr" role="presentation">Sympathomimetic drugs mimic the fight or flight response, affecting monoamines such as dopamine, norepinephri ... Show More
7m 54s
Jun 2024
#525: Cholesterol-Lowering Medication – Dr. Paddy Barrett
<p>Cholesterol-lowering medications, particularly statins, play a pivotal role in reducing low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) concentrations, which are causal markers in atherosclerosis development. The efficacy of these medications is well-do ... Show More
48m 29s
Aug 2023
Podcast 866: Carbamazepine (Tegretol) Overdose
<p dir="ltr"><strong>Contributor: Aaron Lessen MD</strong></p> <p dir="ltr"><strong>Educational Pearls:</strong></p> <p dir="ltr">What is Carbamazepine (Tegretol)?</p> <ul> <li dir="ltr" aria-level="1"> <p dir="ltr" role="presentation">Carbamazepine is an anti-epileptic drug with ... Show More
2m 46s
May 2023
Podcast 853: Critical Care Medications - Vasopressors
<p dir="ltr"><strong>Contributor:</strong> Travis Barlock MD</p> <p dir="ltr"><strong>Educational Pearls:</strong></p> <ul> <li dir="ltr" aria-level="1"> <p dir="ltr" role="presentation">Three categories of pressors: inopressors, pure vasoconstrictors, and inodilators</p> </li> < ... Show More
5m 10s
Jul 2023
313. Stimulant-Associated Cardiomyopathy with Dr. Soraya Azari and Dr. Jonathan Davis
Dr. Amit Goyal (CardioNerds co-founder), Dr. Jessie Holtzman (House Faculty in CardioNerds Academy and cardiology fellow at UCSF), and Dr. Megan McLaughlin (CardioNerds Scholar and cardiology fellow at UCSF) discuss stimulant-associated cardiomyopathy with Dr. Jonathan Davis (Ass ... Show More
39m 39s
Jul 2022
Podcast 801: Push Dose Vasopressors
<p><strong>Contributor: Aaron Lessen, MD</strong></p> <p><strong>Educational Pearls:</strong></p> <ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">There are two common options for push-dose vasopressor: phenylephrine and epinephrine. Both have be ... Show More
3m 10s
Jun 2023
167 - Beyond One-Size-Fits-All: Unraveling the Genetic Tapestry of CYP2D6 Drug Metabolism
<p>In this episode, we review the science behind genetic differences in humans in the CYP2D6 hepatic enzyme responsible for drug metabolism and how these genetic variants can lead to certain drugs being metabolized far too much or far too little, which can cause drug toxicities o ... Show More
35m 18s
Dec 2022
158 - PADing Your Understanding of Peripheral Arterial Disease: A Brief Treatment Overview
In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy, and guideline-directed medication therapy recommendations including the newest evidence for the use of DOACs. Key Concepts Addres ... Show More
49m 23s
Jul 2022
221. Guidelines: 2021 ESC Cardiovascular Prevention – Question #18 with Dr. Jaideep Patel
The following question refers to Section 6.2 of the 2021 ESC CV Prevention Guidelines. The question is asked by Dr. Christian Faaborg-Andersen, answered first by Houston Methodist medicine resident Dr. Najah Khan, and then by expert faculty Dr. Jaideep Patel. Dr. Patel recently ... Show More
7m 15s